These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A pharmacoepidemiologic study of community-dwelling, disabled older women: Factors associated with medication use. Crentsil V; Ricks MO; Xue QL; Fried LP Am J Geriatr Pharmacother; 2010 Jun; 8(3):215-24. PubMed ID: 20624611 [TBL] [Abstract][Full Text] [Related]
3. Effects of Changes in Number of Medications and Drug Burden Index Exposure on Transitions Between Frailty States and Death: The Concord Health and Ageing in Men Project Cohort Study. Jamsen KM; Bell JS; Hilmer SN; Kirkpatrick CM; Ilomäki J; Le Couteur D; Blyth FM; Handelsman DJ; Waite L; Naganathan V; Cumming RG; Gnjidic D J Am Geriatr Soc; 2016 Jan; 64(1):89-95. PubMed ID: 26782856 [TBL] [Abstract][Full Text] [Related]
4. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. Gnjidic D; Hilmer SN; Blyth FM; Naganathan V; Waite L; Seibel MJ; McLachlan AJ; Cumming RG; Handelsman DJ; Le Couteur DG J Clin Epidemiol; 2012 Sep; 65(9):989-95. PubMed ID: 22742913 [TBL] [Abstract][Full Text] [Related]
5. Is Polypharmacy Associated with Frailty in Older People? Results From the ESTHER Cohort Study. Saum KU; Schöttker B; Meid AD; Holleczek B; Haefeli WE; Hauer K; Brenner H J Am Geriatr Soc; 2017 Feb; 65(2):e27-e32. PubMed ID: 28024089 [TBL] [Abstract][Full Text] [Related]
6. Frailty in older men: prevalence, progression, and relationship with mortality. Cawthon PM; Marshall LM; Michael Y; Dam TT; Ensrud KE; Barrett-Connor E; Orwoll ES; J Am Geriatr Soc; 2007 Aug; 55(8):1216-23. PubMed ID: 17661960 [TBL] [Abstract][Full Text] [Related]
7. Frailty and use of health and community services by community-dwelling older men: the Concord Health and Ageing in Men Project. Rochat S; Cumming RG; Blyth F; Creasey H; Handelsman D; Le Couteur DG; Naganathan V; Sambrook PN; Seibel MJ; Waite L Age Ageing; 2010 Mar; 39(2):228-33. PubMed ID: 20075036 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and 10-year outcomes of frailty in older adults in relation to deficit accumulation. Song X; Mitnitski A; Rockwood K J Am Geriatr Soc; 2010 Apr; 58(4):681-7. PubMed ID: 20345864 [TBL] [Abstract][Full Text] [Related]
9. Medication exposure and frailty in older community-dwelling patients: a cross-sectional study. Reallon E; Chavent B; Gervais F; Dauphinot V; Vernaudon J; Krolak-Salmon P; Mouchoux C; Novais T Int J Clin Pharm; 2020 Apr; 42(2):508-514. PubMed ID: 32140916 [TBL] [Abstract][Full Text] [Related]
10. Sedative load and frailty among community-dwelling population aged ≥65 years. Peklar J; O'Halloran AM; Maidment ID; Henman MC; Kenny RA; Kos M J Am Med Dir Assoc; 2015 Apr; 16(4):282-9. PubMed ID: 25434581 [TBL] [Abstract][Full Text] [Related]
11. Association of midlife obesity and cardiovascular risk with old age frailty: a 26-year follow-up of initially healthy men. Strandberg TE; Sirola J; Pitkälä KH; Tilvis RS; Strandberg AY; Stenholm S Int J Obes (Lond); 2012 Sep; 36(9):1153-7. PubMed ID: 22614054 [TBL] [Abstract][Full Text] [Related]
12. Associations of drug burden index with falls, general practitioner visits, and mortality in older people. Nishtala PS; Narayan SW; Wang T; Hilmer SN Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):753-8. PubMed ID: 24723335 [TBL] [Abstract][Full Text] [Related]
13. Socio-demographic determinants of worsening in frailty among community-dwelling older people in 11 European countries. Etman A; Burdorf A; Van der Cammen TJ; Mackenbach JP; Van Lenthe FJ J Epidemiol Community Health; 2012 Dec; 66(12):1116-21. PubMed ID: 22544921 [TBL] [Abstract][Full Text] [Related]
14. Life-space constriction, development of frailty, and the competing risk of mortality: the Women's Health And Aging Study I. Xue QL; Fried LP; Glass TA; Laffan A; Chaves PH Am J Epidemiol; 2008 Jan; 167(2):240-8. PubMed ID: 17906296 [TBL] [Abstract][Full Text] [Related]
15. Exposure to atropinic drugs and frailty status. Moulis F; Moulis G; Balardy L; Gérard S; Montastruc F; Sourdet S; Rougé-Bugat ME; Lapeyre-Mestre M; Montastruc JL; Rolland Y; Vellas B J Am Med Dir Assoc; 2015 Mar; 16(3):253-7. PubMed ID: 25548029 [TBL] [Abstract][Full Text] [Related]
16. Homocysteine, frailty, and all-cause mortality in older men: the health in men study. Wong YY; Almeida OP; McCaul KA; Yeap BB; Hankey GJ; Flicker L J Gerontol A Biol Sci Med Sci; 2013 May; 68(5):590-8. PubMed ID: 23070880 [TBL] [Abstract][Full Text] [Related]
17. Polypharmacy Is Associated With Higher Frailty Risk in Older People: An 8-Year Longitudinal Cohort Study. Veronese N; Stubbs B; Noale M; Solmi M; Pilotto A; Vaona A; Demurtas J; Mueller C; Huntley J; Crepaldi G; Maggi S J Am Med Dir Assoc; 2017 Jul; 18(7):624-628. PubMed ID: 28396180 [TBL] [Abstract][Full Text] [Related]
18. Midlife obesity and risk of frailty in old age during a 22-year follow-up in men and women: the Mini-Finland Follow-up Survey. Stenholm S; Strandberg TE; Pitkälä K; Sainio P; Heliövaara M; Koskinen S J Gerontol A Biol Sci Med Sci; 2014 Jan; 69(1):73-8. PubMed ID: 23640762 [TBL] [Abstract][Full Text] [Related]
19. How do potentially inappropriate medications and polypharmacy affect mortality in frail and non-frail cognitively impaired older adults? A cohort study. Porter B; Arthur A; Savva GM BMJ Open; 2019 May; 9(5):e026171. PubMed ID: 31092652 [TBL] [Abstract][Full Text] [Related]
20. Incidence and Effects of Polypharmacy on Clinical Outcome among Patients Aged 80+: A Five-Year Follow-Up Study. Wang R; Chen L; Fan L; Gao D; Liang Z; He J; Gong W; Gao L PLoS One; 2015; 10(11):e0142123. PubMed ID: 26554710 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]